XTENT , Nasdaq: XTNT.XX
Developing a customizable drug eluting stent to treat coronary artery disease.
Industry: Health Care
First Day Return: +3.0%
Industry: Health Care
| IPO Data | |
|---|---|
| IPO File Date | 08/07/2006 |
| Offer Price | $16.00 |
| Price Range $16.00 - $18.00 | |
| Offer Shares (mm) | 4.7 |
| Deal Size ($mm) | $75 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 01/31/2007 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $75 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Menlo Park, CA, United States |
| Founded | 2002 |
| Employees at IPO | 91 |
| Website www.xtentinc.com | |
XTENT (XTNT.XX) Performance
